Philip Britz-McKibbin is a Professor at the Department of Chemistry and Chemical Biology and Cystic Fibrosis Canada Researcher at McMaster University in Hamilton, Canada. Dr. Britz-McKibbin obtained his BSc in Chemistry (U. Toronto, 1994), and PhD in Analytical Chemistry (UBC, 2000) and a Japan Society for Promotion of Science PDF position in Japan (Hyogo University, 2001-2003) prior to starting his academic position at McMaster. His research group is an affiliate member of The Metabolomics Innovation Centre (TMIC) – Canada’s national metabolomics laboratory. His research interests in bio-analytical chemistry, separation science, mass spectrometry and metabolomics include the design of novel analytical strategies to quantify and identify metabolites of clinical significance in biological samples. Philip’s laboratory aims to discover new biomarkers that support early detection and improved therapeutic interventions with emphasis on inherited metabolic disorders and chronic human diseases, including cystic fibrosis. His research interests include the development of high throughput screening methods for large-scale clinical and epidemiological studies in metabolomics.
Keynote Lecture: New advances in CE-based metabolomics for biomarker discovery: serum metabolic signatures of peripheral artery disease